Domains 3 and 5 of high-molecular-weight kininogen (HK) have been shown to bind to platelets in a zincdependent reaction. However, the platelet-binding proteins responsible for this interaction have not been identified. We have focused on the platelet-binding site for the heavy chain (domain 3), which we approached using a domain 3-derived peptide ligand and isolated binding proteins by affinity chromatography. The domain 3-derived peptide, thrombin, HK, factor XII, as well as antibody to glycocalicin (the N-terminal portion of the a chain of GPIb) recognized a protein at 74 kD. We also isolated the thrombin receptor (PAR 1) at 45 kD, however, none of the above-mentioned ligands bound to this
Introduction
The plasma kinin-forming cascade consists of factor XII, high-molecular-weight kininogen (HK) , and prekallikrein, which interact to generate the vasoactive peptide bradykinin. Activated factor XII converts prekallikrein to kallikrein and kal-likrein digests HK to release bradykinin. Prekallikrein circulates bound to HK and HK also serves as a cofactor for prekallikrein activation by factor XIIa (1) .
HK possesses six domains: the first three are homologous to cysteine protease inhibitors, the fourth domain includes the bradykinin moiety, and domains 5 and 6 interact with negatively charged surfaces and with prekallikrein or factor XI, respectively. HK has been shown to bind to platelets by its heavy and light chains (2) (3) (4) and ,uM zinc is required for binding. The isolated heavy and light chains derived from kinin-free kininogen can each interact with platelets (4) as well as endothelial cells (5) and those interactions are dependent upon peptides within domains 3 and 5, respectively (6, 7) .
HK has been shown to inhibit thrombininduced platelet aggregation (8) and we have presented preliminary data to suggest a direct interaction of HK with GPIb (9) . This is consistent with a recent report in which Bradford et al. (10) showed that HK does not inhibit thrombindependent aggregation of Bernard-Soulier platelets, which lack the GPIb-IX-V complex, and that several antibodies to the complex inhibit HK binding. Although thrombin binds to GPIb, the functional thrombin receptor (PAR-1) is a separate protein, which is cleaved by thrombin, and the newly exposed N-terminus participates in cell activation. Thus HK may interact with the GPIb-IX-V complex to inhibit functions of PAR-I or it might interact with both proteins.
In this report, we identify the extracellular portion of the a chain of platelet membrane GPIb (glycocalicin) as a binding site, which interacts with domain 3 of HK as well as coagulation factor XII in a zinc-dependent reaction. A molecule of 74 kD was initially isolated by affinity chromatography using HK or antibody to glycocalicin as ligand. The intact a chain was then isolated by photoaffinity labeling. We also identified PAR-1 within the HK affinity chromatography eluate; however, there is no evident binding of biotinylated HK or factor XII to it. Preparation of LDC-2 7 and Anti-glycocalicin Antibody Affinity Columns Peptide LDC-27 (reduced and blocked) or antiglycocalicin antibody was coupled with 3M Emphaze Biosupport Medium AB 1 (Pierce Chemical, Rockford, IL) according to the manufacturer's recommendations as described previously (12) . Briefly, 5 mg of the ligand (5 ml) was dialyzed against 0.1 M carbonate buffer, pH 9.0, and sodium citrate was added to a final concentration of 0.6 M. To this, 0.125 g of dry beads was added and mixed for 2 hr at room temperature. This mixture was poured into a small column and washed with 10 vol of phosphate-buffered saline (PBS). The eluate and the washings were collected to determine coupling efficiency, which was calculated to be >70%. Then 3 ml of 3 M ethanolamine, pH 9.0, was added to the column, the column was closed at both ends, and mixed end-over-end for 2.5 hr at room temperature. The column was then washed sequentially with 10 vol each of PBS, 1 M NaCl, and PBS. A control column was also made similarly with no ligand.
Materials and Methods

Materials
Purification of Platelet Membrane Proteins
Platelet packs were obtained from the blood bank and were diluted 1:1 with PBS containing 10 mM EDTA (PBS-EDTA) and centrifuged at 2000 X g. The supernatant was discarded and the pellet resuspended in PBS-EDTA and washed three times. The pellet was then resuspended and centrifuged at 800 X g and the supernatant containing platelets was collected and pelleted. The final pellet was resuspended in homogenization buffer [10 mM Hepes, 150 mM NaCl, 2 mM phenylmethylsulfonylfluoride (PMSF), 1 ,uM aprotinin, 1 ,uM pepstatin, 1 mM EDTA, 0.1% soy bean trypsin inhibitor (SBTI)], and sonicated using a Heat Systems/Ultrasonics (model W225R) sonicator continuously for 2 min on ice and the sonicate centrifuged at 50,000 x g for 1 hr. The pellet, containing the membrane fraction, was resuspended in homogenization buffer containing 1% Triton X-100 and kept at 40C overnight with gentle mixing. This suspension was centrifuged at 50,000 X g for 1 hr. The supernatant, containing solubilized membrane components, was collected and dialyzed against dialysis buffer (homogenization buffer without SBTI and EDTA) containing 0.1 % Triton X-100.
This membrane lysate was applied to the affinity columns and the flow-through was collected. The column was washed with dialysis buffer, eluted with 0. 1 M glycine-HCl, pH 2.5, and 0.5-ml fractions were collected. The column was then washed and re-equilibrated with dialysis buffer containing 50 ,AM zinc chloride. The initial effluent was also made to 50 ,uM in zinc and was applied to the column. The column was again washed and eluted. Both the eluates were neutralized to pH 7.0 by adding a predetermined quantity of 1 M Tris-HCl (pH 9.0) to each tube. Elution was monitored by protein determination and by dot blot using biotinylated peptide. A control column without the ligand was also processed in a similar manner.
Biotinylation of Proteins and Peptides
Biotinylation of proteins and peptides was performed employing NHS-LC-biotin (Pierce) according to the following procedure. Proteins or peptides to be labeled (1 mg/ml) were first dialyzed against 2 x 1 liter of 0.2 M NaHCO3 buffer (pH 8.3). Labeling was initiated by addition of 50 ,lI of a 1 mg/ml solution of biotin freshly dissolved in dimethyl sulfoxide (DMSO). The reaction was allowed to proceed for 4 hr at room temperature with constant but gentle tumble mixing, after which the reaction was stopped and the protein dialyzed, first against 1 liter of the initial dialysis buffer then against 2 X 1 liter PBS, pH 7.5. The degree of biotinylation was verified by ELISA using wells coated with various dilutions of the labeled protein and probing with alkaline phosphatase-conjugated streptavidin (AP-STRAV) or ExtrAvidin (AP-XTRAV).
Iodination of HK
HK was iodinated with Na'251 by iodobeads (Pierce) according to manufacturer's recommendations as modified by Nishikawa et al. (13) .
Following iodination, 125I-labeled HK was separated on a desalting column (Econo-Pac 10 DG, Bio-Rad, Hercules, CA). Specific labeling, determined by trichloroacetic acid precipitation following addition of bovine serum albumin (BSA) as carrier protein, ranged from 2 to 2.5 x 109 cpm/mg protein. HK thus labeled did not lose its coagulant activity, determined according to Proctor and Rapaport (14) , which was 12 U/mg, where 1 U is defined as the coagulant activity present in 1 ml of pooled normal human plasma.
Electrophoreses and Western Blot Analyses SDS-polyacrylamide gel electrophoresis (PAGE) was performed using the buffer system of Laemmli (15) . After electrophoresis, the gels were stained with Coomassie brilliant blue, destained, and dried. For Western blot and ligand blot analyses, the separated proteins were electrotransferred to nitrocellulose membranes and probed with MAbs or biotinylated ligands at a concentration of 0.5 to 1 jig/ml. Bound probes were visualized by alkaline phosphatase-conjugated secondary antibodies or alkaline phosphataseconjugated avidin.
Dot Blot Analyses Dot blot analyses were performed using a dot blot apparatus (Bio-Rad). Samples (0.5 to 1 ,ug of proteins) were added to the wells and dried under vacuum. The nitrocellulose membrane was removed from the apparatus and incubated (1 hr at room temperature) in PBS containing 1% BSA to block the free sites, washed three times in PBST (PBS + 0.05% Tween 20) , and reacted with a predetermined dilution of the biotinylated ligand or monospecific antibody. After 1 hr at room temperature, the membrane was washed and the bound ligand probed by sequential reaction (1 hr each), first with alkaline phosphataseconjugated avidin or secondary antibody followed by a substrate solution (BCIP/NBT, Kirkegaard & Perry Laboratories). After full color development was achieved, the reaction was stopped by first rinsing the residual precipitates from the membrane with PBS, followed by washing with PBS-E (PBS + 1 mM EDTA) for 15 min.
Protein Determinations Protein concentrations were determined by the method of Bradford (16); for proteins containing nonionic detergents, the detergent-compatible, bicinchoninic acid-dependent protein assay (17) was used.
Preparation of Washed Platelets for Binding Assay Blood was obtained from normal healthy adult human donors and mixed with one-sixth volume of acid citrate dextrose. The citrated blood was centrifuged at 800 X g for 20 min at 40C to obtain platelet-rich plasma, which was collected and centrifuged again at 2000 X g for 10 min at 4°C. The platelet pellet was gently suspended in the binding buffer (10 mM HEPES, 11 mM KCI, 1 mM MgCl2, 1 mg/ml BSA, pH 7.4) and gel filtered over Sepharose CL-2B in a 9 X 2.5 cm column that had been equilibrated with the same binding buffer. Platelets were eluted at the void volume.
Binding of 125I-HK to Platelets and Its Inhibition by Anti-GPIb Antibody All binding studies were performed at 370C, without stirring. Washed platelets were incubated in the binding buffer containing labeled HK in the presence or absence of 50 AM zinc.
Aliquots were removed at various time points and centrifuged through a silicone oil barrier to separate the platelets from the unbound proteins, and the bound radioactivity was determined. For inhibition studies, platelets were preincubated with anti-GPIb antibody (10 ,tg/ml) or nonimmune IgG (10 ,ug/ml) for 20 (Fig. 1) .
In the presence of zinc, more prominent protein bands were obtained than in its absence and the major bands had a molecular weight of 45 kD or greater (Fig. IA, lane 3 (Fig. 2, lanes 1, 2) . However, biotinylated thrombin as well as antibody to GPIb bound to the uppermost band at 74 kD (Fig. 2,  lanes 3, 4) . An antibody to the thrombin receptor, however, bound to a band at 45 kD (Fig. IA,  lane 3) , which did not bind HK, factor XII, or thrombin.
To confirm that the 74 kD protein identified corresponds to GPIb, we prepared an affinity column using anti-glycocalicin antibody (18, 19) directed to the N-terminal region of the GPIb a chain and purified proteins from a platelet membrane lysate. The proteins eluted from the column were analyzed on SDS-PAGE. A Coomassie blue-stained gel showed three major bands at 66, 72, and 74 kD (Fig. 3, lane 2 (Fig. 3, lanes 3, 4) as well as to a lesser band at 69 kD.
Zinc-Dependent Binding of HK and Factor XII to Purified Membrane Protein Purified membrane proteins from the peptide affinity column and the anti-glycocalicin antibody affinity column were also compared by dot blot analysis for their binding properties. Biotinylated HK (Fig. 4A,B) as well as biotinylated factor XII (Fig. 4C,D) Of interest is the finding that the band at 33 kD in lane 1 of Figure 6B is gC 1 qR; lane 1 in Figure 6A is too dilute to detect it.
Discussion
High-molecular-weight kininogen (HK) binds to platelets in a zinc-dependent reaction, with binding sites demonstrable on domains 3 and 5 (3, 4) . These same domains have been shown to interact with endothelial cells (6, 7) and neutrophils (20) and specific peptides have been identified as the sites of interaction with endothelial cells (6, 7) . Factor XII also binds to endothelial cells (21) (22, 23 ). This appears to be due to proteolysis during platelet membrane purification, although we could not totally exclude the presence of a cross-reacting and thrombin-binding molecule of lower molecular weight. The thrombin receptor is known to undergo proteolysis to 42-45 kD (23), as we observed it here, and the extracellular domain of the a chain of GPIb, which corresponds to glycocalicin, may be similarly cleaved.
We therefore next approached the binding by a method that does not require solubilization of cell membrane components-namely, photoaffinity labeling. As shown in Figure 6 , the major binding protein for HK is GPIb, its molecular weight corresponds to that reported previously (135 kD), and the antibody to GPIb crossreacts with the anti-glycocalicin antibody utilized in the affinity experiments. Recently, Bradford et al. (10) have demonstrated that antisera to the GPIb-IX-V complex of platelets inhibit HK binding to platelets; our data are consistent with these observations and indicate that binding is to the a chain of GPIb. Thus binding to GPIb modulates functioning of the thrombin receptor. Functional linkage of GPIb and the thrombin receptor is also suggested by HK inhibition of aggregation with no discernable interaction with the thrombin receptor, as reported here. They were also co-isolated with our HK affinity column. A recent report suggests that factor XII may also inhibit thrombin-induced platelet aggregation (24) , and we have demonstrated (Fig. 2) factor XII binding to GPIb as well.
The significance of HK (or factor XII) binding to GPIb is best appreciated by the binding inhibition study (Fig. 5 ) that demonstrates 55-60% inhibition with a monospecific antibody directed to the a chain of GPIb. This same antiserum also identifies the 74 kD band to which HK binds by ligand blot (Fig. 3) in a zinc-dependent reaction (Fig. 4) . Since the plasma kininogens are substrates from which bradykinin is generated, their cell membrane expression may serve to modulate the delivery of this peptide to its receptor(s). Prekallikrein binds to HK, and both HK and factor XII bind to GPIb, thus all components of the kinin-forming cascade can be present along the surface of platelets. Binding of HK to GPIb may also sterically interfere with the ability of thrombin to cleave the thrombin receptor. Finally, gC 1 qR has been shown to be a major HK binding protein of endothelial cells; however, it interacts with domain 5 rather than domain 3. Although platelets contain far less gC 1 qR than do endothelial cells, we isolated it as a trace protein by photoaffinity labeling using native HK (Fig. 6B , lane 1) but not by ligand affinity chromatography with a domain 3 peptide.
